TOP HEADLINES

Featured Story

Diagnostics companies homing in on rapid mobile tests to quell Ebola outbreak

Amid efforts to counter the deadly Ebola outbreak, researchers and companies are homing in on rapid mobile tests as a more effective way to prevent the disease's spread.

QuantuMDx teams up with Swiss nonprofit to develop handheld TB test

QuantuMDx is teaming up with a Swiss nonprofit organization to develop its handheld test for tuberculosis, building momentum for a full commercial rollout of its innovative diagnostic tool.

Nanosphere reels in $18.4M in stock sale

Molecular diagnostics developer Nanosphere reeled in $18.4 million in a stock sale with the proceeds slotted to be used for general corporate purposes and working capital.

'See-through' sensors for the brain are transparent to imaging diagnostics

Researchers at the University of Wisconsin-Madison have come up with an implantable sensor so thin that scientists studying the brain can see through it using a wide range of imaging technologies.

FDA grants bioMérieux emergency authorization for one-hour Ebola Dx

BioFire, a subsidiary of French diagnostics outfit bioMérieux, was granted emergency authorization from the FDA for two of its Ebola tests.

MORE NEWS

From Our Sister Sites

FierceBiotech Research

U.K. researchers have hit upon a drug combination that appears to combat lung cancer by triggering self-destruction in tumor cells.

FiercePharma

Express Scripts--which has made its feelings well known when it comes to the high cost of Gilead's next-gen hepatitis C drugs--says it may quickly change its preferred drug formulary to favor a anticipated challenger from the Illinois company, Reuters reports, provided it's clinically equivalent--and less expensive, of course.